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Abstract To examine the neural function of Csk (C-terminal 
Src kinase), a membrane-targeted form of Csk (Src/Csk) and its 
kinase-defective variant (DK-Src/Csk) were expressed in the 
embryonic carcinoma cell line P19. Expression of Src/Csk, but 
not DK-Src/Csk, caused reduction of the specific activities of Src 
and Fyn in the differentiated PI 9 cells. During neural 
differentiation, the specific activity of Src was elevated in the 
control P19 cells, whereas the activation was completely 
eliminated in the Src/Csk transfectant. In normally differentiated 
P19 cells, cross-linking of a cell adhesion molecule, LI, induced a 
short-term activation of Src and Fyn. In the Src/Csk transfec-
tant, LI stimulation induced delayed activation of Src and Fyn 
peaking at much lower levels than in the control cells. Src/Csk 
transfectants developed normally in the initial stages of neural 
differentiation, but exhibited an apparent defect in cell-to-cell 
interaction, i.e. neurite fasciculation and aggregation of cell 
bodies, in the latter stages. These findings imply that Csk is 
involved in the regulation of Src family kinases that play roles in 
cell-to-cell interaction mediated by cell adhesion molecules. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The development of the nervous system is known to be 
regulated by a variety of protein tyrosine kinases. The neural 
functions of the receptor-type tyrosine kinases have been rel-
atively well characterized [1], while those of the non-receptor-
type tyrosine kinases including Src family kinases remain ob-
scure. The Src family consists of 10 members which share a 
unique structure containing Src homology 3 (SH3) domain, 
SH2 domain and C-terminal regulatory domain [2]. In the 
lymphoid system, it has been shown that Src family kinases 
serve as downstream factors of receptor molecules, such as T-
and B-cell receptors, to convert extracellular signals into intra-
cellular tyrosine phosphorylation events [3]. Expression pat-
terns of Src family kinases in the nervous system have impli-
cated their roles in differentiation and function of neural cells 
[4—12]. Knockout mice for neural Src family kinases were 
generated to evaluate their in vivo roles, but the analyses 
were unsuccessful due to the gene redundancy among the 
family members [13-16]. In an in vitro system, however, it 
was observed that neurons derived from Src knockout mice 
exhibited a defect in neurite extension on a cell adhesion mol-
ecule, LI [17], and that neurons from Fyn knockout mice 
showed impaired neurite outgrowth on N-CAM [18]. More-
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over, a functional interaction between Fyn and large myelin 
associated glycoprotein (L-MAG) was demonstrated [19]. 
These findings suggest that Src family kinases play certain 
roles in cell-to-cell interaction mediated by neural cell adhe-
sion molecules. However, the molecular mechanism of their 
neural function and their physiological roles remains to be 
clarified. 
The kinase activity of Src family kinases is regulated neg-
atively by the phosphorylation of their C-terminal regulatory 
tyrosines [20]. The phosphorylation is mainly contributed by 
another non-receptor tyrosine kinase, Csk (C-terminal Src 
kinase), which was originally protein purified as a kinase 
that specifically acts on the regulatory site of the Src family 
in vitro [21,22]. Disruption of the csk gene in mice leads to 
extraordinary activation of Src, Fyn and Lyn, resulting in 
embryonic lethality with impaired development of the neural 
tissues [23,24]. Thus Csk is thought to be an essential regu-
lator of Src family kinases during the development of the 
nervous system. However, the embryonic lethality of Csk 
knockout mice has hampered detailed analysis of Csk func-
tion. 
To study the neural function of Csk and its major targets, 
Src family kinases, we here employed an embryonic carcino-
ma cell line, P19, as an in vitro model of neural differentia-
tion. P19 is a multipotential stem cell line that can be induced 
to differentiate into neural cells by treatment with retinoic 
acid [25]. In this study, we generated multiple P19 clones 
which constitutively expressed a membrane-targeted form of 
Csk (Src/Csk), a fusion protein having a myristilation signal 
of Src [26]. It is known that the membrane-localized Csk can 
act on Src family kinases more effectively than wild type Csk 
[26,27]. The effects of Src/Csk expression on the kinase activ-
ity of Src family kinases and neural differentiation of PI 9 cells 
were investigated here. 
2. Materials and methods 
2.1. Cell culture 
P19 mouse embryonic carcinoma cells were maintained in a-modi-
fied minimal essential medium (a-MEM) supplemented with 10% fetal 
bovine serum (FBS) at 37°C in a 5% C02 atmosphere. Differentiation 
of P19 cells into neural cells was carried out essentially by the method 
of McCarrick and Andrews [28]. Briefly, cells were first allowed to 
aggregate in bacterial-grade dishes in a-MEM containing 10% FBS 
and 1 uM retinoic acid. After 4 days, the aggregates were dispersed 
into single cells by treatment with 0.01% trypsin. The cell suspension 
(2X106 cells) was then re-plated onto a 100-mm tissue culture-grade 
dish coated with 5 ug/ml poly-L-lysine to induce neural differentiation. 
After a further 2 days, 5 ug/ml cytosine arabinoside was added to the 
medium to kill proliferating non-neural cells. 
2.2. Vector constructions and transfection 
The Neo expression vector (pKJ2) driven by the promoter and 
polyadenylation signal of the phosphoglycerate kinase 1 (PGK) gene 
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was digested with PstI to cut out a Neo open reading frame (ORF), 
blunted and ligated to a Mlul linker. The Hin&lll-SaH fragment of 
Src/Csk (a gift from Dr. A. Veillete) was also blunted, ligated to a 
Mlul linker, and inserted into the pKJ2-derived vector (PGK-Src/ 
Csk). A kinase-deficient variant of Src/Csk (PGK-DK-Src/Csk) was 
generated by substituting Lys-222 for Arg by the Kunkel method. The 
expression vector was co-transfected with an intact pKJ2 vector into 
undifferentiated P19 cells by electroporation with an electric pulse of 
250 V and 960 up. Stable transfectants were selected by culturing in 
the presence of geneticin (150 |xg/ml) for 14 days, and surviving col-
onies were picked up. 
2.3. Western blotting 
To determine subcellular localization of Src/Csk, P19 cells were 
rinsed twice with cold phosphate-buffered saline (PBS) and harvested 
in a hypotonic buffer (10 mM Tris-HCl pH 7.4, 1 mM phenylmethyl-
sulfonyl fluoride (PMSF), 1 mM EDTA, 1 mM sodium orthovana-
date, 0.1 mM sodium molybdate, and 2 mM MgCl2). The cells were 
disrupted with a Teflon pestle homogenizer, and the cytosolic and 
membrane-containing fractions were separated by ultracentrifugation 
at 70 000 Xg for 90 min. For detection of neural marker proteins, 
cells were lysed with RIPA buffer (10 mM Tris-HCl pH 7.4, 0.15 M 
NaCl, 1% Nonidet P-40, 1 mM EDTA, 0.1% sodium dodecyl 
sulfate (SDS), 0.5% sodium deoxycholate, 5 mM p-mercaptoethanol, 
1 mM PMSF, 1 mM sodium vanadate and 10 ng/ml aprotinin), 
and the supernatant obtamed by ultracentrifugation was used 
for analysis. Proteins separated by SDS-PAGE were transferred elec-
trophoretically onto a nitrocellulose membrane (Schleicher and 
Schuell). After blocking with 1% skim milk (or bovine serum albumin 
(BSA)) in Tween-TBS (Tris-buffered saline containing 0.1% Tween-
20) the membrane was probed with primary antibody. The immuno-
reactivity was visualized with an enhanced chemiluminescence system 
(Dupont) using a secondary antibody conjugated with horseradish 
peroxidase (HRP). 
2.4. Immunoprecipitation and in vitro kinase assay 
Cells were rinsed twice with ice-cold PBS, then lysed with 400 |xl of 
ice-cold RIPA buffer or TNE buffer (20 mM Tris-HCl pH 7.4, 0.15 M 
NaCl, 1% Nonidet P-40, 1 mM EDTA, 5 u.M P-mercaptoethanol, 
1 mM PMSF, and 10 lig/ml aprotinin). The cell lysate (200 itg of 
protein) was precleared with Pansorbin cells (Calbiochem), and in-
cubated with anti-v-Src antibody (Mab327, Oncogene Science) or 
anti-Fyn antibody (Wako) for 1 h at 4°C. Subsequently, 0.1 |ig of 
anti-mouse IgG was added and the mixture was further incubated for 
30 min at 4°C. The immune complex was recovered by incubation 
with 20 ul of 10% Pansorbin cells for 30 min at 4°C, then washed once 
with a cushion of 500 |ll RIPA buffer containing 1 M sucrose, twice 
with RIPA buffer, and twice with TNE buffer. The obtained immu-
noprecipitate was resuspended in 20 |il of TNE buffer. To estimate the 
protein amount of the kinase, half of the immunoprecipitate was 
subjected to Western blotting, and the intensity of signal was deter-
mined densitometrically. 
For in vitro kinase assay, an aliquot (2 |il) of immunoprecipitated 
kinase was mixed with 18 ul of reaction mixture (10 mM PIPES-
NaOH pH 7.0, 10 mM MnCl2, 2.5 itg of rabbit muscle enolase (Sig-
ma)) and the reaction was initiated by the addition of 5 uCi of [y-
32P]ATP (3000 Ci/mmol). After incubation for 10 min at 30°C, 20 ul 
of 2 X SDS-PAGE sample buffer was added and the sample was boiled 
for 3 min. The phosphorylated proteins were resolved by SDS-PAGE 
and visualized by autoradiography. Radioactivity incorporated into 
enolase was semi-quantified by using a Bioimage Analyzer BAS3000 
(Fuji). 
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Fig. 1. A: Expression of a membrane-targeted variant of Csk (Src/Csk) in P19 cells. Wild type cells (WT), the control transfectant (Neo), three 
Src/Csk transfectants (SI, A2, and D5), and a DK-Src/Csk transfectant (C9) were fractionated into cytosolic (C) and membrane-containing 
fractions (M). Proteins in the cytosolic (10 |xg) and the membrane-containing fractions (30 |xg) were subjected to Western blotting with anti-Src 
or anti-Csk antibody. The locations of Src, Src/Csk and endogenous Csk are indicated. A faint band seen in the cytosolic fractions, which mi-
grated more slowly than Src/Csk, was non-specific signal detected by anti-Csk antibody. B, C: Effect of Src/Csk expression on the activities of 
Src and Fyn. Src (B) and Fyn (C) were immunoprecipitated from differentiated (2 days after neural induction) wild type cells (WT), a control 
transfectant (Neo), DK-Src/Csk transfectant (C9) and the three Src/Csk transfectants (SI, A2 and D5), and subjected to in vitro kinase assay. 
The activity was quantified by counting the radioactivity incorporated into enolase, and the relative specific activity was obtained by dividing 
the activity by protein amount of the kinase in the immunoprecipitates. 
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2.5. Immunocytochemistry 
P19 cells differentiated in 35-mm tissue-culture dishes were rinsed 
with PBS, fixed in 4% paraformaldehyde in PBS, and subsequently 
permeabilized in PBS containing 0.2% Triton X-100. After blocking 
with 1% BSA in Tween-TBS, specimen was reacted with a primary 
antibody diluted with Tween-TBS, and washed three times with PBS. 
Specimen was then incubated with a secondary antibody conjugated 
with HRP. Immunoreactivity was detected with a staining buffer (0.05 
M Tris-HCl pH 6.8, 0.02% 3,3'-diaminobenzidine tetrahydrochloride 
(DAB), 0.5% nickel(II) ammonium sulfate hexahydrate, and 0.005% 
hydrogen peroxide). The primary antibodies used were anti-microtu-
bule associated protein 2 (MAP2) and anti-syntaxin rabbit polyclonal 
antibodies (gifts from Dr. M. Niinobe, Osaka University), anti-neuro-
filament 160 kDa protein (NF) monoclonal antibody (Boehringer 
Mannheim), anti-N-CAM monoclonal antibody (Chemicon Internat-
ional Inc.), and three kinds of anti-Ll polyclonal antibodies, recog-
nizing immunoglobulin-like, fibronectin type Ill-like, and intracellular 
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Fig. 2. Effect of Src/Csk expression on Src activity during neural 
differentiation of P19 cells. A: Total cell lysates were prepared from 
the control transfectant (Neo) and a Src/Csk transfectant (A2) at 
various stages of differentiation (M, undifferentiated monolayer cul-
ture; 2, 2-day cultures after neural induction; 4, 4-day cultures; 
6, 6-day cultures), and analyzed for the expression of Src by West-
ern blotting (upper panels). Src protein was immunoprecipitated 
from the cell lysates and the protein amounts in the immunoprecipi-
tates were verified by Western blotting with anti-Src antibody (mid-
dle panels). The immunoprecipitates were then subjected to in vitro 
kinase assays with enolase as a substrate. B: The activity of Src was 
quantified by counting the radioactivity incorporated into enolase, 
and the specific activity was estimated by dividing the activity by 
the amount of Src protein in the immunoprecipitates. Relative spe-
cific activities against the specific activity of Src in undifferentiated 
culture were plotted. 
domains (gifts from Dr. A. Asou, Tokyo Metropolitan Institute of 
Gerontology). 
3. Results and discussion 
3.1. Expression of a membrane-targeted Csk in PI9 cells 
The expression vectors were transfected into P19 cells to 
generate clones constitutively expressing a membrane-targeted 
form of Csk (Src/Csk), and its kinase-defective variant (DK-
Src/Csk). Among the multiple clones obtained, three clones 
expressing Src/Csk (SI, A2, and D5) and a clone expressing 
DK-Src/Csk (C9) were selected for analyses. To confirm the 
expression of Src/Csk, proteins from cytosolic and membrane-
containing fractions were subjected to Western blotting with 
anti-Src and anti-Csk antibodies (Fig. 1). The Src/Csk protein 
which migrated slightly more slowly than endogenous Csk 
was detected only in the membrane-containing fractions where 
Src protein was also enriched. We previously analyzed fibro-
blast cell lines expressing wild type Csk and Src/Csk, and 
found that Src/Csk, even if its expression level was lower 
than that of endogenous Csk, could effectively act on Src to 
suppress its activation during mitosis [27]. Co-localization on 
a membrane structure might induce efficient and specific con-
tact between Csk and Src family kinases. 
To verify the function of Src/Csk, wild type cells (WT), a 
control transfectant (Neo), Src/Csk transfectants (SI, A2, and 
D5) and DK-Src/Csk transfectant (C9) were induced to differ-
entiate for 4 days, and the specific activities of Src and Fyn in 
these cell lines were compared. In this study, two types of Src, 
c-Src and a neuron-specific form of c-Src (c-Src+) [5], were 
assayed simultaneously, thus the activity of 'Src' represents 
the total activity of c-Src and c-Src+. Although c-Src+ has a 
somewhat higher specific activity than c-Src [6], it has been 
shown that c-Src+ is under the control of Csk in a similar 
manner to c-Src [29]. In Src/Csk transfectants (SI, A2, and 
D5), the specific activity of Src was decreased to about 50% of 
that of wild type PI9 cells (WT) (Fig. IB). The specific activity 
of Fyn was also repressed to about 20-60% of that of wild 
type cells (Fig. 1C). The control transfectant (Neo) and DK-
Src/Csk transfectant (C9) did not show significant change in 
the specific activity of Src or Fyn. Under our conditions, 
dominantly negative effect of DK-Src/Csk was not observed 
in the C9 line. These findings demonstrate that ectopically 
expressed Src/Csk was capable of inhibiting the activities of 
Src family kinases. 
3.2. Effect of Src/Csk expression on Src activity during neural 
differentiation 
To examine the effect of Src/Csk expression on the change 
in Src activity during neural differentiation, the specific activ-
ities of Src in the control (Neo) and a Src/Csk transfectant 
(A2) at various stages of neural differentiation were estimated. 
In the control cells, the specific activity of Src was increased 
with neural differentiation, a greater than 5-fold increase 
being achieved in differentiated 6-day culture (Fig. 2A,B). In 
contrast, the specific activity of Src was almost equal level 
during neural differentiation of Src/Csk transfectant, although 
neural induction of Src protein was normally observed. It has 
already been reported that expression of Src, especially c-
Src+, is induced during neural differentiation [30] and that 
the specific activity of Src is also augmented in differentiated 
nervous system [29]. From these observations, it is suggested 
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Fig. 3. Effect of Src/Csk expression on the activation of Src and Fyn induced by cross-linking of a cell adhesion molecule LI. A: The control 
transfectant (Neo) and Src/Csk transfectant (A2) were allowed to differentiate for 5 days. After incubation with an anti-Ll antibody (50 ug/ml) 
recognizing an extracellular domain for the indicated time (min), the cells were lysed in TNE buffer. The expression levels of Src and Fyn were 
confirmed by Western blotting, and Src and Fyn proteins were immunoprecipitated from the cell lysate (50 ug protein). The kinase activities of 
Src and Fyn were determined with enolase as a substrate. B: Whole cell lysates were prepared from the control cells and Src/Csk transfectant 
following LI stimulation for the indicated time (min), and aliquots (10 ug protein) were subjected to Western blotting with anti-phosphotyro-
sine antibody (4G10). The molecular sizes of the marker proteins are indicated in kDa. C, D: The specific activities of Src (C) and Fyn (D) 
were calculated from 4 (Src) and 3 (Fyn) independent experiments (a representative result is shown in panel A). Relative values against the ac-
tivity in unstimulated control cells are expressed as means ± S.E.M. 
that constitutively high activity of Src is required for progres-
sion or maintenance of neural differentiation. In Src/Csk 
transfectants, the constitutive activation of Src was almost 
completely eliminated. Therefore, Src/Csk transfectants might 
provide a good system for studying the mechanism and phys-
iological role of Src activation during neural differentiation. 
3.3. Effect of Src/Csk expression on the activation of Src 
family kinases induced by cross-linking of a cell adhesion 
molecule, LI 
To examine the effect of Src/Csk expression on the poten-
tially Src-mediated signaling pathway evoked by cell-to-cell 
interaction, we here investigated the activity change in Src 
family kinases after cross-linking of LI using anti-Ll anti-
body. LI is a neural cell adhesion molecule consisting of im-
munoglobulin-like and fibronectin type Ill-like extracellular 
domains and a short cytoplasmic tail, and is known to be a 
key molecule involved in neurite fasciculation [31-34]. In dif-
ferentiated control cells, the basal activities of Src and Fyn 
were substantially higher than those in Src/Csk transfectant. 
Nevertheless, rapid (peaking within 5 min after stimulation) 
and significant activation of Src and Fyn was observed (Fig. 
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Fig. 4. A: Immunocytochemical analyses of the expressions of neural marker proteins and cell adhesion molecules in the control transfectant 
(Neo) and Src/Csk transfectant (A2). The control (A-E) and Src/Csk (F-J) transfectants were allowed to differentiate for 6 days, and the cul-
tures were immunostained with anti-MAP2 (A, F), anti-syntaxin (B, G), anti-NF160 (C, H), anti-N-CAM (D, I), and anti-Ll (E, J) antibodies. 
B: Western blot analyses of the expressions of marker proteins. Whole cell lysates (20 ug protein) of control (Neo) and Src/Csk transfectant 
(A2) at various differentiation stages were subjected to Western blotting with antibodies against the indicated marker proteins. M, undifferenti-
ated monolayer culture; A, cell aggregates in suspension culture; 2, 2-day cultures after neural induction; 4, 4-day cultures; 6, 6-day cultures. 
3A,C,D). Surprisingly, it was found in this study that Fyn was 
also functionally coupled with LI stimulation. In Src/Csk 
transfectants, in which Src family kinases were present as sup-
pressed forms, relative specific activities of Src and Fyn were 
apparently increased by LI stimulation. However, the peaking 
times of the activation were significantly delayed (beyond 10 
min after stimulation), and the absolute values of their specific 
activities were much less than those in the control cells. These 
findings suggest that Src as well as Fyn could act as intra-
cellular transducers of signals evoked by cell-to-cell interac-
tion mediated by LI, and that Csk is involved in the regula-
tion of this signaling pathway. 
Consistent with the activities of Src family kinases, the 
basal levels of tyrosine phosphorylation of cellular proteins 
were already high in differentiated control cells (Fig. 3B). 
Probably because the phosphorylation was nearly saturated, 
there was no significant change in tyrosine phosphorylation 
even after LI stimulation. In contrast, the basal levels of ty-
rosine phosphorylation were very low in Src/Csk transfec-
tants, indicating that the activities of Src family kinases 
were efficiently suppressed by Src/Csk in these cells. Although 
several reports proposed that Csk has some targets other than 
Src family kinases [35,36], there was no induction of any ty-
rosine phosphorylated protein in Src/Csk transfectant. This 
suggests that Src/Csk mainly acts on Src family kinases to 
suppress their functions under our conditions. In Src/Csk 
transfectants, however, induction of tyrosine phosphorylation 
by LI stimulation was detected in parallel with the activation 
profiles of Src and Fyn, supporting that Src family kinases are 
important mediators of LI signaling. Thus it is likely that the 
constitutive activation of Src in differentiated normal cells is 
induced by an active cell-to-cell interaction potentially medi-
ated by LI, although the mechanism remains to be studied. 
3.4. Phenotype of Src/Csk transfectants 
When the three Src/Csk transfectants and a DK-Src/Csk 
transfectant were cultured in an undifferentiated state, no sig-
nificant change was observed in rates of cell growth or cell 
morphology as compared with those of wild type cells. Fur-
thermore, the initial events of differentiation (until 4 days 
after neural induction) appeared to be indistinguishable 
from those of wild type cells, in that they generated small 
cell clusters and extended neurites to form a fine network 
(data not shown). These observations demonstrate that the 
expression of Src/Csk does not affect the determination of 
neural cell fate. Since Src was present as a suppressed form 
in undifferentiated P19 cells, the effect of Src/Csk on Src was 
moderate in the early stages of differentiation. Previously it 
was reported that overexpression of c-Src and c-Src+ in P19 
cells rather inhibited neural differentiation, suggesting that the 
activity of Src is not essential for commitment of neural differ-
entiation [37]. This implies that Src should be down-regulated 
in undifferentiated cells until neural differentiation is commit-
ted by certain mechanism. Indeed, the level of Csk expression 
was greater in developing neural cells than in mature ones 
[29]. 
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In the control cells, thereafter, the dispersed small cell clus-
ters became integrated into larger cell aggregates and the fine 
networks of neurites were converted into large meshed net-
works consisting of thick neurite bundles (neurite fascicula-
tion) within 6 days after neural induction (Fig. 4A (A-E)). In 
contrast, Src/Csk transfectants were still dispersed into small 
cell clusters and their neurites were no longer integrated into 
thick bundles (Fig. 4A (F-J)). DK-Src/Csk transfectant exhib-
ited a morphology indistinguishable from that of wild type 
cells (data not shown). 
To further characterize the phenotype of Src/Csk transfec-
tant, expressions of some neuronal marker proteins and cell 
adhesion-related proteins were analyzed by immunocytochem-
istry. In the differentiated control cells, MAP2, syntaxin, NF, 
LI and N-CAM immunoreactivities were detected in the ag-
gregates of both neuronal cell bodies and neurite bundles (Fig. 
4A (A-E)). Src/Csk transfectant also showed high immuno-
reactivity against anti-MAP2, anti-syntaxin, and anti-N-CAM 
antibodies (Fig. 4A (F,G,I)). However, the immunoreactivities 
for NF and LI were extremely low in Src/Csk transfectant 
(Fig. 4A (H,J)). The expression of these proteins was further 
confirmed by Western blotting (Fig. 4B). Consistent with the 
results of immunocytochemistry, induction of NF and LI 
during neural differentiation was suppressed in Src/Csk trans-
fectants. Induction of other neural proteins including neuron-
specific enolase, focal adhesion kinase (FAK), Fyn, Src and 
Csk was not significantly affected by the expression of Src/Csk 
(data not shown). 
Taken these phenotypes together with the finding that Src-
mediated signaling through LI was attenuated in Src/Csk 
transfectants, it is plausible that abrogated cell-to-cell interac-
tion mediated by LI is one of the major causes of the pheno-
type. Indeed, interference with Ll-Ll interaction of normal 
P19 cells by the addition of antibody against extracellular 
domain of LI caused a phenotype very similar to that of 
Src/Csk transfectant (unpublished observation). Thus Src 
family kinases and Csk may play important roles in the reg-
ulation of cell-to-cell interaction which is an essential element 
for the progression of neural differentiation. However, expres-
sion of neurofilament protein was also downregulated in Src/ 
Csk transfectant. The possibility that Src family kinases/Csk is 
involved in the regulation of multiple gene expressions re-
quired for neural differentiation should be examined in a fu-
ture study. 
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